In the past week, FOLD stock has gone down by -8.10%, with a monthly decline of -7.63% and a quarterly plunge of -19.12%. The volatility
The stock has a 36-month beta value of 0.76. Opinions on the stock are mixed, with 3 analysts rating it as a “buy,” 3 as
The 36-month beta value for FOLD is also noteworthy at 0.75. There are mixed opinions on the stock, with 3 analysts rating it as a
Amicus Therapeutics Inc (NASDAQ: FOLD) has seen a rise in its stock price by 3.76 in relation to its previous close of 11.43. However, the
Moreover, the 36-month beta value for FOLD is 0.76. Analysts have varying opinions on the stock, with 3 analysts rating it as a “buy,” 3
© 2024, Fueled by Smart TechOne
